Skip to main content

Table 2 APOA5 and APOC3 polymorphism frequencies in patients with bulbar plaque present or absent.

From: Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene

A) Plaque present
Pat Num APOC3 sstI rs5128 APOA5 1131T > C rs662799 APOA5 S19W rs3135506  
101     
76     
90 GC TC   
36   TC   
35     
44 GC TC   
28     
86    SW  
63 GC TC   
4 GC TC   
87 GC TC   
20 GC TC   
45 GC TC   
71   TC   
27     
48    SW  
37 GC TC   
52     
38    SW  
93 GC TC   
6     
16     
89     
3    SW  
91 GC TC SW  
n 10 12 5  
B) Plaque absent
Pat Num APOC3 sstI rs5128 APOA5 1131T > C rs662799 APOA5 S19W rs3135506  
46     
100     
40     
72    WW  
33   TC   
62 GC    
60     
65     
97 GC    
21 GC TC   
73     
102     
5    SW  
14   TC   
50    SW  
8   TC   
95     
61   TC   
12     
64     
47 GC    
85   TC SW  
94     
11     
1     
53     
25     
98     
34 GC    
59     
31     
23    SW  
74   TC SW  
70    SW  
66    SW  
n 5 7 7/1  
C: Summary of APOA5 and APOC3 polymorphism fre quencies
APOC3 sstI APOA5-1131T > C APOA5 S19W Plaque Present Plaque Absent
GG TT SS 9 18
GG TC SS 2 4
GG TT SW 4 5
GG TC SW 0 2
GG TT WW 0 1
GC TT SS 0 4
GC TC SS 9 1
GC TC SW 1 0